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Abstract
Background: The incidence of fungal healthcare-associated infection (HAI) has increased in a major teaching
hospital in the northern part of Taiwan over the past decade, especially in the intensive care units (ICUs). The
purpose of this study was to determine the factors that were responsible for the outbreak and trend in the ICU.
Methods: Surveillance fungal cultures were obtained from “sterile” objects, antiseptic solutions, environment of
infected patients and hands of medical personnel. Risk factors for comparison included age, gender, admission
service, and total length of stay in the ICU, Acute Physiology and Chronic Health Evaluation (APACHE) II scores at
admission to the ICU, main diagnosis on ICU admission, use of invasive devices, receipt of hemodialysis, total
parenteral nutrition (TPN) use, history of antibiotic therapy before HAI or during ICU stay in no HAI group, and ICU
discharge status (ie, dead or alive). Univariable analysis followed by multiple logistic regression analysis was
performed to identify the independent risk factors for ICU fungal HAIs and ICU mortality.
Results: There was a significant trend in ICU fungal HAIs from 1998 to 2009 (P < 0.001). A total of 516 episodes of
ICU fungal HAIs were identified; the rates of various infections were urinary tract infection (UTI) (54.8%), blood
stream infection (BSI) (30.6%), surgical site infection (SSI) (6.6%), pneumonia (4.5%), other sites (3.5%). The fungi
identified were: yeasts (54.8%), Candida albicans (27.3%), Candida tropicalis (6.6%), Candida glabrata (6.6%), Candida
parapsilosis (1.9%), Candida species (0.8%), and other fungi (1.9%). Candida albicans accounted for 63% of all
Candida species. Yeasts were found in the environment of more heavily infected patients. The independent risk
factors (P < 0.05) of developing ICU fungal HAIs from all sites were TPN use, sepsis, surgical patients, mechanical
ventilation and an indwelling urinary catheter. The independent risk factors for ICU fungal UTI included TPN use,
mechanical ventilation and an indwelling urinary catheter. The independent risk factors for ICU fungal BSI included
TPN use, sepsis, and higher APACHE II score. The independent risk factors for ICU fungal pneumonia included TPN
use, surgical patients. The independent risk factors for ICU fungal SSI included surgical patients, and TPN use. The
odds ratios of TPN use in various infection types ranged from 3.51 to 8.82. The risk of mortality in patients with ICU
fungal HAIs was over 2 times that of patients without ICU HAIs in the multiple logistic regression analysis
(P < 0.001).
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Conclusions: There was a secular trend of an increasing number of fungal HAIs in our ICU over the past decade.
Patients with ICU fungal HAIs had a significantly higher mortality rate than did patients without ICU HAIs. Total
parenteral nutrition was a significant risk factor for all types of ICU fungal HAIs, and its use should be monitored
closely.
Keywords: Intensive care unit, Fungal infection, Outbreak surveillance, Candida, Total parenteral nutrition
Background
The incidence rate for invasive fungal infections has
increased globally over the past 2 to 3 decades [1-3],
especially in healthcare settings [4-6]. Along with this
trend, these infections occurred more often in the non-
neutropenic, critically ill patients [5,7-9] than in those
patients who were neutropenic or had received organ
transplantation in the past. Candida species comprised
the majority of these pathogenic fungi [2,5,7]. In the
United States (US), a national investigation of the
epidemiology of sepsis from 1979 through 2000 reported
that the rate of sepsis induced by fungi increased by 207
percent [1]. In the healthcare settings, Candida species
were reported to be the seventh most common nosoco-
mial pathogen in the National Nosocomial Infection
Surveillance (NNIS) system conducted by Centers for
Disease Control and Prevention (CDC) in the US during
the 1980’s [10,11]. The incidence of nosocomial candidemia
was also noted to increase substantially (219-487%) in both
large and small hospitals at this time [12]. In a subsequent
report using data from the NNIS system during the period
of 1990 to 1992,Candida species were the sixth most
common nosocomial pathogens from all sites and fourth
most common pathogens in nosocomial blood stream
infections (BSIs) [13]. When studies were limited to inten-
sive care units (ICUs), Candida species were the fourth
most common pathogens in ICU nosocomial infections
(NIs) and BSIs in the 1980’s from the NNIS data [10,14].
Between 1992 and 1998, according to surveillance data
collected from 205 combined medical-surgical ICUs in the
US, Candida species and other fungi became the second
most common pathogens in nosocomial urinary tract infec-
tions (UTIs) and BSIs [15].
In Taiwan, the burden of fungal healthcare-associated
infection (HAI), formerly NI is also heavy, especially in
the ICUs. A study from the Taiwan Nosocomial Infection
Surveillance System (TNIS) reported Candida species to
be the most common pathogen among the HAIs from 21
ICUs in 17 medical centers in 2009 [16]. According to this
analysis, Candida species was the most common pathogen
among the nosocomial UTIs, and the second most com-
mon pathogen among the nosocomial BSIs in these ICUs
[16]. In one of these medical centers, Candida species and
other yeasts had become the leading pathogens responsible
for NIs hospital-wide since 1993, and Candida species were
also the leading pathogens in nosocomial BSIs since with
the highest rate in the medical ICU [5,17].
In our hospital, the overall incidence rate for fungal
HAIs remained stable before 2006, although the incidence
of candidal BSIs did increase in 2004, [18] however, the
overall incidence of fungal HAIs rose abruptly in 2007,
especially in the ICUs. The department of infection control
initiated an outbreak investigation at the beginning of 2008.
This included surveillance cultures and risk factor analysis
for patients admitted to the ICU. Our aim was to determine
if there was a common source, or if any specific factors
were correlated with the trend of fungal HAIs. Although
there have been reports of outbreak investigations or risk
factor analyses for fungal HAIs, a complete study which
includes risk factor analysis using a continuous prospective
database along with an outbreak investigation is unique.
Methods
Hospital and setting
This study was conducted in a 42–bed adult medical–
surgical ICU with more than 1500 admissions (age 18
years or older) per year located in a 2900–bed major
teaching hospital in the northern part of Taiwan.
Healthcare-associated infections, the onsets of which
were more than 48 hours after admission to the ICU or
within 48 hours after discharge or transfer to a ward,
were considered to be acquired in the ICU [19,20]. The
study was approved by the Institutional Review Board of
Taipei VGH with a complete waiver of informed consent
(2012-01-026BC).
Nosocomial surveillance
A prospective hospital-wide surveillance for HAIs was
established in 1982. A single infection-control profes-
sional surveyed the ICU during the entire period of this
study [21,22]. All patients in the ICU were monitored for
HAIs that affected particular body sites. The standard
surveillance protocols and HAI site definitions, including
BSI, UTI, surgical site infection (SSI), pneumonia and
others sites, were those recommended by the CDC in the
US [19,20,23]. Reports of HAI cases were also verified
by an infectious disease specialist. Although the term
“nosocomial” has been replaced by “healthcare-associated”
infection since 2008, most of the case definitions remain
unchanged.
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Definition of health-care associated infections
Nosocomial infections or HAIs are defined as a localized
or systemic condition resulting from an adverse reaction
to the presence of an infectious agent or its toxin. There
must be no evidence that the infection was present or
incubating at the time of admission to the acute care set-
ting [19,23]. Thus, colonization should not be mistaken
as NIs or HAIs by case definitions.
Symptomatic UTI was defined when a patient had one
or more of the following signs or symptoms with no
other recognized cause: fever (> 38°C), dysuria, urgency,
frequency, or suprapubic tenderness and (1) the patient
had a positive urine culture, that is, ≥ 105 microorgan-
isms per cc of urine with no more than two species of
microorganisms, or (2) pyuria (urine specimen with ≥ 10
white blood cells/mm3) and a positive urine culture
of ≥ 103 and < 105 CFU/ml with no more than 2 species
of microorganisms. To detect UTI organisms, a urine
sample was aseptically aspirated from the sampling port
of a urinary catheter and cultured quantitatively [23].
Asymptomatic bacteriuria was removed from the case
definitions of HAIs by CDC of the US in January 2009.
Our department of infection control follows the modifi-
cation of case definitions accordingly since January 2010.
Laboratory–confirmed BSI was defined when a patient
had a recognized pathogen cultured from one or more
blood cultures and the microorganism cultured from
blood was not related to an infection at another site.
Common skin contaminants (e.g., coagulase–negative
staphylococcus [CoNS]) required culture from two or
more blood cultures drawn on separate occasions or at
least one blood culture for a patient with intravascular
devices and microorganisms of the tip culture identical
to those of the blood culture [23].
A SSI must meet the following criterion: Infection
occurs within 30 days after the operative procedure, and
the infection appears to be related to the operative
procedure and involves soft tissues of the incision or in-
fection involves any part of the body, and patient has at
least 1 of the following: (1) purulent drainage from the
deep incision or from the organ/space component of the
surgical site (2) An incision spontaneously dehisces or is
deliberately opened by a surgeon and is culture-positive
or not cultured when the patient has at least 1 of the
following signs or symptoms: fever (> 38°C), or localized
pain or tenderness. (3) an abscess or other evidence of
infection involving the incision is found on direct exam-
ination, during reoperation, or by histopathologic or
radiologic examination. (4) organisms isolated from an
aseptically obtained culture of fluid or tissue in the
organ/space [23].
Pneumonia was defined when a patient had a new or
progressive infiltrate, consolidation, cavitation, or pleural
effusion on chest radiograph and had the following signs
or symptoms: new onset of purulent sputum or change in
character of sputum. To detect pneumonia microorgan-
isms, tracheal aspirates obtained via endotracheal tube
suction or tracheostomy tube suction were cultured [23].
Data collection
In the combined ICU, data were collected prospectively
for every patient who was admitted. The data collected
for all patients included demographic characteristics
(age, gender, admission service, and total length of stay
in the ICU), Acute Physiology and Chronic Health
Evaluation (APACHE) II scores at the time of admission
to the ICU, main diagnosis on ICU admission, use of
invasive devices (mechanical ventilator, central venous
catheter (CVC), indwelling urinary catheter, arterial cath-
eter, and wound drainage tube), receipt of hemodialysis,
history of antibiotic therapy within 7 days before the HAI
was identified or during the ICU stay in patients without
HAI, and ICU discharge status (dead or alive). Information
collected about each HAI included use of total parenteral
nutrition (TPN) before HAI, the dates and sites of
infection, and identified pathogens. Our microbiology
laboratory identified fungi to the species level for
most specimens except urine and sputum. For ordinary
cultures of urine and sputum, fungal isolates were
reported only as yeast or mold unless there was a special
request. Identification of yeasts was performed by Vitek 2
YST card (bioMerieux Inc.).
The data about TPN use in ICU patients without HAI
were provided by our TPN team from their prospective
database. The TPN team is in charge of the consultation,
preparation and quality control of TPN; and the
members consist of physicians, dietitians, pharmacists
and nurses. Prescription of antibiotics is monitored by
the infectious disease specialists, and prophylactic anti-
fungals are not recommended in the non-neutropenic,
non-transplant ICU patients.
Surveillance cultures
Surveillance cultures were performed from 16 March
2008 to 31 March 2008. Fungal cultures were obtained
from the hands of all ICU healthcare workers including
10 physicians, 84 nurses, 2 administrative assistants, and
4 cleaning staff. Cultures were performed when
personnel were off duty and after they had washed their
hands. Cultures were also obtained from the environ-
ment of 11 patients with ICU fungal HAIs. These sites
included tap water and drains, faucets, the surface of
ventilators and monitors, patients’ drinking water, water
used for sputum suctioning, bedside tables and bed rails.
Fungal cultures were also obtained from “sterile” inani-
mate objects and disinfectants sampled from the ICU,
respiratory care unit, neurological care unit, cardiovas-
cular surgical unit, infectious disease ward and the
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supply center. These sterile inanimate objects included
saline vials, sputum suction tubes, gauze, cotton swabs,
urinary catheters, and urinary bag gel. All of these were
sealed properly and never opened before cultures were
obtained. Disinfectants included povidone iodine and
antiseptic alcohol solution.
A sterile swab method and Sabaouraud dextrose agar
were adopted for fungal cultures. The sterile swab was
dampened with Sabaouraud dextrose broth when dry
site cultures were performed such as on the surface of
machines and hands of healthcare workers. All the
specimens were incubated at 35°C for 14 days. The fun-
gal isolates were then preserved in a −70°C refrigerator.
Surveillance culture of TPN preparation is performed by
the department of infection control as a routine at all
times, including the whole study period.
Statistical analysis
The x2 test was used to calculate a P value for the linear
trend. To define an outbreak, the mean incidence rate of
fungal HAIs from 1998 to 2006 in the ICU was used as
the expected incidence before an abrupt increase was
detected in 2007. An incidence exceeding the upper 99%
confidence interval (CI) limit of the expected incidence
was considered to be an outbreak.
By using the database described above, comparisons of
all the collected variables were performed between
patients with various types of ICU fungal HAIs and
patients without ICU HAIs from January 2007 to April
2008. Descriptive analysis of all the collected variables
was performed first. The x2 test was then used to evalu-
ate the differences in categorical variables and independ-
ent t tests were used to evaluate the differences in
numerical variables between the 2 groups. To identify
independent risk factors that were associated with ICU
fungal HAIs and ICU mortality, multiple logistic regression
analyses were used to build up the models and adjust
for confounders. All tests were 2-tailed, and P < 0.05
was considered to be statistically significant. All the
analyses were performed using SPSS software, version
17.0 (SPSS).
Results
The trend of fungal HAIs in the ICU from 1998 to 2009
is depicted in Figure 1. A total of 516 episodes of ICU
fungal HAIs were identified; the rates of various
infections were UTI (283, 54.8%), BSI (158, 30.6%), SSI
(34, 6.6%), pneumonia (23, 4.5%), other sites (18, 3.5%).
It appears that the rise in HAIs is parallel to the rise of
UTIs, while BSIs increase to a much lesser extent. The P
values for the linear trends of all sites, UTIs and BSIs
were all < 0.001. The mean incidence of overall ICU
fungal HAIs was 2.1 episodes per thousand person-days
from 1998 to 2006, with an upper limit of 99% of CI 3.2.
The incidence in 2007 was 7.5 episodes per thousand
person-days, which was over 3 times the expected
incidence. An outbreak of fungal HAIs in the ICU was
suspected and an investigation was initiated. More strict
infection control measures such as reinforcement of
hand washing, auditing aseptic techniques and antibiotic
prescription were adopted, and there seemed to be a
tendency for decreased incidence after 2007, but the
P value was not significant (P = 0.27).
Outbreak surveillance
The species-specific distribution and trend for all ICU
fungal HAIs from 1998 to 2009 are depicted in Figure 2.
A total of 516 fungal strains were isolated. The fungi
identified were: yeasts (283, 54.8%), Candida albicans
(141, 27.3%), Candida tropicalis (34, 6.6%), Candida
glabrata (34, 6.6%), Candida parapsilosis (10, 1.9%),
Candida species (4, 0.8%), and other fungi (10, 1.9%).
Candida albicans accounted for 63% of all Candida spe-
cies and it appears that that the rise in Candida albicans
is parallel to the rise of BSIs in Figure 1. The rise in
yeasts is parallel to the rise of UTIs in Figure 1. All of
the various fungi showed a tendency for an increase of
similar magnitude. No evidence of marked increase of a
single species was observed.
Surveillance cultures of 39 samples from sterile objects
and 47 samples from disinfectants were harvested. No
fungal growth was detected in any of these specimens.
Cultures yielded no fungal growth from the hands of any
ICU healthcare worker either. During the whole study
period, no TPN contamination event had been noted.
Eleven patients were noted to have ICU fungal HAIs.
Culture sites included urine, sputum, ascites, blood and
pus. These patients were unrelated to one another in
terms of unit location. Among them, 3 patients were
noted to have 2 episodes of fungal HAI. In the first
patient, the infection sites were UTI and CVC tip; yeasts
were detected from the water used for sputum suction-
ing and the surface of the mechanical ventilator and the
faucet. In the second patient with UTI and pneumonia
infection sites, yeast was detected in the water used for
sputum suctioning. In the third, 2 episodes of fungal
UTI were noted and yeast was detected in his drinking
water. In the remaining 8 patients with a single episode
of fungal HAI, no fungus was detected in the environ-
mental cultures.
Patient demographic data
From January 2007 to April 2008, a total of 1674
patients admitted to the ICU had no ICU HAI; their
mean age was 67.5 ± 18.0 years and 71.2% were male.
The mean APACHE II score was 22.5 ± 7.6, and 305
patients died for a mortality rate of 18.2%. There were
186 patients with acquired ICU fungal HAIs; the rate of
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various infections were UTI (89, 47.8%), BSI (43, 23.1%),
pneumonia (24, 12.9%), SSI (17, 9.1%), other sites (13,
7.0%). Their mean age was 71.6 ± 16.0 years and 70.4%
were male. The mean APACHE II score was 24.7 ± 7.0,
and 56 of these patients died for a mortality rate of
30.1%. The mortality rate was significantly higher in the
fungal HAI group (P < 0.001). The proportion of TPN
use was 2.6% in the non-HAI group and 19.4% in fungal
HAI group; the average number of TPN utilization days
before infection were 6.9 ± 6.7 vs 19.2 ± 1.7 days (P < 0.001).
The results of univariable analysis are shown in Table 1.
Other variables with significant differences (P < 0.05)
between the 2 groups included mean length of ICU stay,
surgical service, diagnosis of digestive system disease,
sepsis, prior antibiotic therapy, and use of invasive devices
including a central line, mechanical ventilator, urinary
catheter, wound drainage and hemodialysis.
Risk factors
On multiple logistic regression analysis, significant risk
factors for all sites and various types of ICU fungal HAIs
after controlling for covariables are shown in Table 2.
The independent risk factors (P < 0.05) of developing
ICU fungal HAIs from all sites were TPN use (OR = 4.83,
95% CI, 2.80-8.34, P < .001), sepsis (OR = 2.71, 95% CI,
1.24-5.92, P = .012), mechanical ventilation (OR = 2.05,
95% CI, 1.40-2.99, P < .001), surgical patients (OR = 1.89,
95% CI, 1.27-2.80, P = .002) and an indwelling urinary
catheter (OR = 1.52, 95% CI, 1.06-2.20, P = .025). The
independent risk factors for ICU fungal UTIs were TPN
use (OR = 3.51, 95% CI, 1.69-7.31, P = .001), mechanical
ventilation (OR = 2.85, 95% CI, 1.73-4.69, P < .001), and an
indwelling urinary catheter (OR = 1.64, 95% CI, 1.01-2.67,
P = .045). The independent risk factors of developing ICU
fungal BSIs were TPN use (OR = 8.47, 95% CI, 4.07-17.63,
P < .001), sepsis (OR = 5.26, 95% CI, 1.70-16.27, P = .004)
and higher APACHE II score (OR = 1.06, 95% CI, 1.02-
1.11, P = .007). The independent risk factors for ICU
fungal pneumonia were TPN use (OR = 8.07, 95% CI,
3.24-20.13, P < .001) and surgical patients (OR = 3.46, 95%
CI, 1.44-8.28, P = .005). The independent risk factors for
ICU fungal SSIs were surgical patients (OR = 11.79, 95%
CI, 2.49-55.74, P = .002) and TPN use (OR = 8.82, 95% CI,
3.27-23.81, P < .001).
Predictors of ICU mortality were identified by multiple
logistic regression analysis and are shown in Table 3.
After adjustment for confounders, the risk of mortality
in patients with ICU fungal HAIs was more than 2 times
that of patients without ICU HAIs (OR = 2.16, 95% CI,
1.51-3.08, P < .001). Other predictors of ICU mortality
included surgical patients (OR = 1.78, 95% CI 1.37-2.31,
P < .001), a main diagnosis of digestive system disease
(OR = 1.76, 95% CI 1.29-2.39, P < .001), sepsis (OR = 2.03,
95% CI 1.15-3.58, P = .014), neoplasm (OR = 1.83, 95% CI,
1.35-2.48, P < .001), and being on a mechanical ventilator
(OR = 1.37, 95% CI, 1.05-1.81, P = .022).
Discussion
Our study began with an outbreak investigation of ICU
fungal HAI. Nosocomial fungal outbreaks induced by a
common exogenous source have been reported in the
literature [11]. These have included contamination of
milk bottles [24], parenteral nutrition [25], and IV medi-
cation [26]. Outbreaks induced by yeast carried on the
Figure 2 The species-specific distribution and trend for ICU
fungal healthcare-associated infections from all sites.
Figure 1 Trend for incidence of ICU fungal healthcare-associated infections from blood stream infection (BSI), urinary tract infection
(UTI), surgical site infection (SSI), pneumonia, other sites and all sites.
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hands of healthcare workers have also been reported
[27-29]. There was no evidence of cross transmission or
common source outbreak in our study. It was more
likely a secular trend; however, yeasts were detected in
the environment of more heavily infected patients. This
finding still points out the importance of traditional
infection control measures such as hand washing and
environmental hygiene. Unfortunately, the fungal stocks
of the environmental yeasts that were found failed to
grow, so we cannot compare the species and genotypes of
isolates yielded from the patients and their surroundings.
The second part of our study focused on an analysis of
risk factors. Five independent risk factors were identified
for all sites of ICU fungal HAI by the multivariable ana-
lysis, which included TPN use, sepsis, surgical patients,
mechanical ventilation and an indwelling urinary catheter.
These results are similar to those of previous studies,
[30-34] though the case definitions of our study were
different from others. Most of the previous studies defined
cases by fungal growth from sterile or non-sterile body
sites, or histology finding, or the EORTC/MSG criteria
[34]. However, active surveillance on HAIs is a common
practice in the hospitals worldwide, especially in the ICUs.
The clinical implications from our study which defined
cases with standardized HAI definitions can be closer to
the daily practice in the ICUs.
Systemic review was performed by the Fungal Infection
Risk Evaluation (FIRE) Study group to identify and
summarize the important risk factors from published
studies with multivariable analyses, risk prediction models
and clinical decision rules for invasive fungal diseases
(IFDs) in critically ill, adult patients. Meta-analysis was not
performed due to the heterogeneity of these studies [34].
In this systemic review, the following risk factors were
found in multiple studies to be significantly associated
with IFD: surgery, TPN, fungal colonization, renal replace-
ment therapy, infection/sepsis, mechanical ventilation,
diabetes, APACHE II or III scores [34]. Five (surgery,
TPN, mechanical ventilation, infection/sepsis, APACHE II
score) of the 8 “important” risk factors reported by the
FIRE Study group were also independent risk factors iden-
tified in various infection types of our study. The signifi-
cant risk factors in our study were TPN use, mechanical
ventilation and an indwelling urinary catheter in fungal
Table 1 Demographic characteristics, univariable analysis between patients with ICU fungal HAIs and patients without
ICU HAIs
Variables No HAI Fungal HAI p
valuen = 1674(%) n = 186(%)
Age, years mean ± SD, 67.5 ± 18.0 71.6 ± 16.0 0.001
APACHE II score, mean ± SD 22.5 ± 7.6 24.7 ± 7.0 <0.001
ICU stay before infection, mean ± SD 6.9 ± 5.7 9.8 ± 7.1 <0.001
Length of ICU stay, mean ± SD 6.9 ± 5.7 20.9 ± 14.7 <0.001
Total parenteral nutrition use before infection, days, mean ± SD 6.9 ± 6.7 19.2 ± 1.7 <0.001
Total parenteral nutrition use (yes) 44(2.6) 36(19.4) <0.001
Gender (male) 1192(71.2) 131(70.4) 0.865
Service (surgical) 643(38.4) 105(56.5) <0.001
Main diagnosis(yes)
Neoplasms 356(21.3) 40(21.5) 0.939
Digestive system 334(20.0) 54(29.0) 0.003
Respiratory system 272(16.2) 21(11.3) 0.078
Genitourinary system 174(10.4) 14(7.5) 0.218
Sepsis 51(3.0) 13(69.9) 0.005
7days before fungal infection with antibiotic therapy 1042(62.2) 141(75.8) <0.001
Mortality in ICU 305 (18.2) 56 (30.1) <0.001
Invasive procedures (yes)
Central venous catheter 1550(92.6) 178(95.7) <0.001
Mechanical ventilator 1139(68.0) 148(79.6) 0.001
Urinary catheter 854(51.0) 123(66.1) <0.001
Wound drainage 1550(92.6) 178(95.7) <0.001
Hemodialysis 417(24.9) 65(34.9) 0.003
SD, Standard deviation; APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; HAI, healthcare-associated infection.
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UTI; TPN use, sepsis, and higher APACHE II score in
fungal BSI; TPN use, surgical patients in fungal pneu-
monia; surgical patients and TPN use in fungal SSI.
Total parenteral nutrition was a significant risk factor
for all types of ICU fungal HAIs; the odds ratios were
3.51 in UTI, 8.47 in BSI, 8.07 in pneumonia, 8.82 in SSI,
4.83 in all sites infections.
The independent risk factor, patients with an indwel-
ling urinary catheter, identified in UTI of our study had
been reported in other studies; though they are not
mentioned in the FIRE Study. A urinary catheter was
included in Leon’s report from the EPCAN study group,
but it was not a significant risk factor for proven fungal
infection in comparison with the fungal colonization
group [30]. They performed weekly surveillance cultures
of urine, tracheal, and gastric samples, and compared
risk factors between patients with unifocal or multifocal
colonization and proven candidal infection. This may be
explained by the fact that Candida species are frequently
isolated from urine specimens from urinary catheters,
whether symptomatic or not; especially when the patient is
medicated with antibacterial agents [15]. The utilization
rate of urinary catheters was high in both groups (colonized
98.5% vs. proven infection 95.9%) of Leon’s study, with
broad spectrum antibiotics administered to 98% of the
colonized vs. 100% of the proven infection group. In this
case, a urinary catheter should be considered a common
risk factor for both groups instead of an independent risk
factor for proven fungal infection. In our study, the 2
groups for comparison were patients with ICU fungal HAI
Table 3 Predictors of ICU mortality
Variables Coefficients SE OR (95% CI) p value
Fungal HAI (yes/no) 0.77 0.18 2.16 (1.51-3.08) <0.001
Service (surgical) 0.58 0.14 1.78 (1.37-2.31) <0.001
Digestive system(yes/no) 0.56 0.16 1.76 (1.29-2.39) <0.001
Sepsis(yes/no) 0.71 0.29 2.03 (1.15-3.58) 0.014
Neoplasms (yes/no) 0.60 0.15 1.83 (1.35-2.48) <0.001
Mechanical ventilator (yes/no) 0.32 0.14 1.37 (1.05-1.81) 0.022
Results of multivariable analysis.
ICU, intensive care unit; SE, Standard error; OR, Odds ratio; CI, Confidence interval; HAI, healthcare-associated infection.
Table 2 Logistic regression analysis of risk factors for fungal infection
Variables Urinary tract infection Blood stream infection Pneumonia Surgical site infection All infection sites
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Age (>65 years) 0.90 0.54-1.50 0.70 0.30-1.34 1.45 0.58-3.62 0.58 0.23-1.48 0.94 0.64-1.40
Gender (male) 0.78 0.48-1.27 0.77 0.41-1.45 1.78 0.69-4.62 1.03 0.38-2.79 0.95 0.65-1.40
Service (surgical) 1.52 0.92-2.51 1.62 0.81-3.23 3.46* 1.44-8.28 11.79* 2.49-55.74 1.89* 1.27-2.80
APACHE II score 1.01 0.98-1.04 1.06* 1.02-1.11 1.03 0.97-1.09 0.99 0.93-1.06 1.01 0.99-1.04
ICU stay before infection(days) 0.98 0.95-1.01 1.00 0.97-1.03 1.01 0.99-1.03 0.99 0.95-1.04 1.00 0.98-1.02
antibiotic therapy 0.82 0.47-1.42 0.64 0.31-1.32 0.60 0.23-1.60 1.42 0.52-3.87 0.87 0.57-1.31
TPN 3.51* 1.69-7.31 8.47* 4.07-17.63 8.07* 3.24-20.13 8.82* 3.27-23.81 4.83* 2.80-8.34
Neoplasms 0.88 0.46-1.69 0.81 0.33-1.98 1.13 0.36-3.51 1.59 0.44-5.79 0.96 0.57-1.61
Respiratory system 0.90 0.43-1.88 0.60 0.18-2.03 1.06 0.26-4.33 — — 0.79 0.42-1.47
Digestive system 1.03 0.53-2.01 1.21 0.51-2.88 1.84 0.60-5.60 2.61 0.78-8.72 1.32 0.80-2.19
Genitourinary system 0.76 0.32-1.81 1.00 0.32-3.11 1.20 0.30-4.79 — — 0.72 0.36-1.44
Sepsis 1.60 0.56-4.57 5.26* 1.70-16.27 3.18 0.53-18.98 2.89 0.22-37.77 2.71* 1.24-5.92
Central line 2.63 0.61-11.24 0.90 0.20-3.99 0.51 0.11-2.46 6.80 — 1.21 0.50-2.92
Mechanical ventilator 2.85* 1.73-4.69 1.71 0.89-3.26 1.67 0.76-3.69 1.45 0.53-3.98 2.05* 1.40-2.99
Hemodialysis 0.70 0.36-1.37 0.72 0.29-1.80 1.67 0.62-4.47 3.08 0.87-10.81 1.21 0.74-1.98
Foley catheter 1.64* 1.01-2.67 1.02 0.56-1.88 2.00 0.92-4.35 0.92 0.37-2.33 1.52* 1.06-2.20
Wound drainage 0.76 0.29-2.02 1.52 0.56-4.12 0.15 0.02-1.43 1.01 0.29-3.55 0.96 0.49-1.88
OR, Odds Ratio; CI, Confidence interval; APACHE, Acute Physiology and Chronic Health Evaluation;
TPN, Total Parenteral Nutrition.
*: P value < 0.05; —: too few case numbers to calculate.
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vs no HAI. Asymptomatic bacteriuria was still included as
a specific infection type of healthcare associated UTIs
during the study period according to the case definitions.
Diagnoses of sepsis, admission to the surgical ICU
service and mechanical ventilation were significant risk
factors for both ICU fungal HAIs and ICU mortality;
these factors, especially sepsis and surgical patients,
cannot be avoided in daily ICU practice. Early treatment
had been documented to improve the outcome of candi-
demia, [35,36] although early diagnostic tools are still
inadequate. Empirical or preemptive antifungal therapy
has generally been accepted as a strategy under such
circumstances; [37] therefore, when signs of ICU HAI
appear; and more risk factors for fungal HAI exist, then
stronger empirical antifungal therapy is indicated. Fungal
ICU HAI was shown to be an independent predictor for
ICU mortality in our study. Avoiding risk factors for
ICU fungal HAIs, especially TPN use, may therefore
improve ICU morbidity and mortality.
The mortality rate of patients with ICU fungal HAIs
was noted to be over 2 times that of patients without
ICU HAIs in our study. This was consistent with other
reports in the literatures [30,38,39]. Candidemia has
resulted in mortality rates as high as 50-70% [17,39-41].
Candiduria was documented to precede candidemia in
the ICU, and itself had a mortality rate of 31.3% [40].
Fungal wound infections have been reported to be inde-
pendently associated with mortality in burn patients
[38]. These studies support our finding that patients
with ICU fungal HAIs have a higher mortality rates than
patients without HAIs regardless of the affected site.
The rates and species distribution of fungal HAIs have
differed geographically and institutionally, [9,42] and
strains of Candida species resistant to antifungals have
been increasing [43]. It is important for each healthcare
unit to have its own epidemiologic knowledge about
fungal HAIs in order to monitor the trend and formulate
a strategy to control it.
Some limitations of our study should be noted. Firstly,
our study was limited by the pre-existing database. Some
factors listed in other studies such as corticosteroid use
and the presence of chronic diseases were lacking. We
did not specify chronic diseases among the variables
because they had been included in the calculation of the
APACHE II score. Corticosteroid use and chronic
diseases as variables were not found to be significant risk
factors in other studies [30,31]. Overall, most of the
important risk factors were included in our study [34].
Secondly, the effort of environmental cultures from ICU
patients was incomplete; because, surveillance cultures
were not performed in patients with no HAI to see
whether there were any differences. Finally, the informa-
tion about the prescription of antibiotics was inadequate.
The policy regarding the use of antibiotics may be
correlated with fungal HAIs, and should be reviewed
more comprehensively. However, no major new classes of
antibiotics were introduced into our hospital during the
study period. The prescription of antibiotics is complicated
in the ICU; this could be the subject of a future study.
Conclusions
There has been a secular trend of increasing fungal
HAIs in our ICU over the past decade. Patients with
ICU fungal HAIs had a significantly higher mortality
rate than did patients without ICU HAIs. Total paren-
teral nutrition was a significant risk factor for all types
of ICU fungal HAIs, and its use should be monitored
closely.
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